Abstract
Sleep complaints are reported by 40–60 % of menopausal women. Poor sleep is a risk factor for cardiovascular disease, diabetes, and obesity. The effect of menopausal hormone therapy on sleep quality is unclear. A systematic review and meta-analysis were conducted to summarize the efficacy of menopausal hormone therapy on self-reported sleep quality. Electronic databases (PubMed, Scopus, Ovid MEDLINE, EMBASE, EBM Reviews CENTRAL, and PsycInfo) were searched from 2002 to October 2015. Randomized trials assessing the effect of menopausal hormone therapy with a minimum follow up of 8 weeks were included. Titles, abstracts, and full texts were screened independently and in duplicate. Primary outcome included sleep items within a questionnaire, scale or diary. Standardized mean differences across trials were pooled using random-effects models. The search identified 424 articles, from which 42 trials were included. Seven trials at a moderate to high risk of bias enrolling 15,468 women were pooled in meta-analysis. Menopausal hormone therapy improved sleep quality in women who had vasomotor symptoms at baseline [standardized mean difference –0.54 (−0.91 to −0.18), moderate quality evidence]. No difference was noted when women without such symptoms were analyzed separately or combined. Across 31 sleep quality questionnaires, daytime dysfunction was the most evaluated sleep domain. Menopausal hormone therapy improves sleep in women with concomitant vasomotor symptoms. Heterogeneity of trials regarding study population, formulations, and sleep scales; limit overall certainty in the evidence. Future menopausal hormone therapy trials should include assessment of self-reported sleep quality using standardized scales and adhere to reporting guidelines.
Similar content being viewed by others
References
L. Howden, J. Meyer, Age and sex composition: 2010. 2010 Census Briefs (2011)
Z.A. Al-Safi, N. Santoro, Menopausal hormone therapy and menopausal symptoms. Fertil. Steril. 101, 905–915 (2014)
P. Sarrel, D. Portman, P. Lefebvre et al., Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause 22, 260–266 (2015)
B. Ettinger, S.M. Wang, R.S. Leslie et al., Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause 19, 610–615 (2012)
L. Danckers, J.E. Blumel, S. Witis et al., Personal and professional use of menopausal hormone therapy among gynecologists: a multinational study (REDLINC VII). Maturitas 87, 67–71 (2016)
C.A. Stuenkel, S.R. Davis, A. Gompel et al., Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100, 3975–4011 (2015)
H.M. Kravitz, P.A. Ganz, J. Bromberger, L.H. Powell, K. Sutton-Tyrrell, P.M. Meyer, Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 10, 19–28 (2003)
M. Bruyneel, Sleep disturbances in menopausal women: aetiology and practical aspects. Maturitas 81, 406–409 (2015)
F.S. Luyster, P.J. Strollo Jr., P.C. Zee, J.K. Walsh, Sleep: a health imperative. Sleep 35, 727–734 (2012)
E.B. Devine, Z. Hakim, J. Green, A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults. Pharmacoeconomics 23, 889–912 (2005)
S. Schutte-Rodin, L. Broch, D. Buysse, C. Dorsey, M. Sateia, Clinical guideline for the evaluation and management of chronic insomnia in adults. J. Clin. Sleep Med. 4, 487–504 (2008)
P.R. Deshpande, S. Rajan, B.L. Sudeepthi, C.P. Abdul Nazir, Patient-reported outcomes: a new era in clinical research. Perspect. Clin. Res. 2, 137–144 (2011)
I. Wiklund, Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Fundam. Clin. Pharmacol. 18, 351–363 (2004)
D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151(264–269), W64 (2009)
E.S. LeBlanc, M.B. Neiss, P.E. Carello, M.H. Samuels, J.S. Janowsky, Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 14, 191–202 (2007)
S.D. Harlow, M. Gass, J.E. Hall et al., Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging. Climacteric 15, 105–114 (2012)
J. Eden, L. Levit, A. Berg, S. Morton eds. Finding What Works in Health Care: Standards for Systematic Reviews. (National Academy of Sciences, Washington, DC, 2011)
T. McGinn, P.C. Wyer, T.B. Newman, S. Keitz, R. Leipzig, G.G. For, Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 171, 1369–1373 (2004)
J. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] (The Cochrane Collaboration, 2011).
N. Meader, K. King, A. Llewellyn et al., A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Syst. Rev. 3, 82 (2014)
J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, Measuring inconsistency in meta-analyses. BMJ 327, 557–560 (2003)
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014
D.J. Buysse, C.F. Reynolds 3rd, T.H. Monk, S.R. Berman, D.J. Kupfer, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193–213 (1989)
H. Savolainen-Peltonen, H. Hautamaki, P. Tuomikoski, O. Ylikorkala, T.S. Mikkola, Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy. Menopause 21, 732–739 (2014)
A.M. Sherman, S.A. Shumaker, P. Sharp et al., No effect of HRT on health-related quality of life in postmenopausal women with heart disease. Minerva Ginecol. 55, 511–517 (2003)
J. Hays, J.K. Ockene, R.L. Brunner et al., Effects of estrogen plus progestin on health-related quality of life. N. Engl. J. Med. 348, 1839–1854 (2003)
G. Saletu-Zyhlarz, P. Anderer, G. Gruber et al., Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J. Sleep Res. 12, 239–254 (2003)
A.B. Heinrich, O.T. Wolf, Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study. Neuropsychobiology 52, 17–23 (2005)
N. Kalleinen, O. Polo, S.L. Himanen, A. Joutsen, P. Polo-Kantola, The effect of estrogen plus progestin treatment on sleep: a randomized, placebo-controlled, double-blind trial in premenopausal and late postmenopausal women. Climacteric 11, 233–243 (2008)
A.F. Polisseni, A.T. Andrade, L.C. Ribeiro et al., Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. Maturitas 74, 172–178 (2013)
A. Elfituri, F. Sherif, M. Elmahaishi, H. Chrystyn, Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal women. Maturitas 52, 52–59 (2005)
B.R. Bhavnani, F.Z. Stanczyk, Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action. J. Steroid Biochem. Mol. Biol. 142, 16–29 (2014)
J.M. Kling, B.A. Lahr, K.R. Bailey, S.M. Harman, V.M. Miller, S.L. Mulvagh, Endothelial function in women of the Kronos Early Estrogen Prevention Study. Climacteric 18, 187–197 (2015)
D. Serrano, L. Mariani, S. Mora et al., Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT. Maturitas 55, 69–75 (2006)
H. Joffe, L.F. Petrillo, A. Koukopoulos et al., Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J. Clin. Endocrinol. Metab. 96, E1044–E1054 (2011)
D.J. Buysse, S. Ancoli-Israel, J.D. Edinger, K.L. Lichstein, C.M. Morin, Recommendations for a standard research assessment of insomnia. Sleep 29, 1155–1173 (2006)
M.H. Hall, C.E. Kline, S. Nowakowski, Insomnia and sleep apnea in midlife women: prevalence and consequences to health and functioning. F1000Prime Rep. 7, 63 (2015)
D.J. Buysse, Sleep health: can we define it? Does it matter? Sleep 37, 9–17 (2014)
H. Hachul, L.R. Bittencourt, M.L. Andersen, M.A. Haidar, E.C. Baracat, S. Tufik, Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women. Int. J. Gynaecol. Obstet. 103, 207–212 (2008)
Guidance for Industry: Estrogen and Estrogen/Progesting Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms-Recommendations for Clinical Evaluation http://google2.fda.gov/search?q=estrogen&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&requiredfields=-archive%3AYes&output=xml_no_dtd&getfields=* accessed 08/05/16
P.S. Eichling, J. Sahni, Menopause related sleep disorders. J. Clin. Sleep Med. 1, 291–300 (2005)
J.L. Shifren, M.L. Gass, The North American Menopause Society recommendations for clinical care of midlife women. Menopause 21, 1038–1062 (2014)
Acknowledgments
D.C., M.R.G., and G.S.B. were supported by TL1 TR000137 from the National Center for Advancing Translational Science, a component of the National Institutes of Health. V.M.M. is supported by National Institutes of Aging P50-AG44170 and the Mayo Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic Supplementary Information
Rights and permissions
About this article
Cite this article
Cintron, D., Lipford, M., Larrea-Mantilla, L. et al. Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis. Endocrine 55, 702–711 (2017). https://doi.org/10.1007/s12020-016-1072-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1072-9